Suchergebnisse - "Tada, Toshifumi"

PubPharm (492)

1

Ultrasound-based steatosis grading system using 2D-attenuation imaging : an individual patient data meta-analysis with external validation

enthalten in: Hepatology (Baltimore, Md.) | 2024

von Hobeika, C. | Ronot, M. | Guiu, B. | +19

2

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

3

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents

enthalten in: Journal of gastroenterology and hepatology | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +15

4

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

5

Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older : Multicenter study

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Hatanaka, T. | Kakizaki, S. | Hiraoka, A. | +45

6

Four cases of non-Helicobacter pylori Helicobacter-infected gastritis with duodenal spiral bacilli

enthalten in: Helicobacter | 2024

von Agawa, H. | Tsukadaira, T. | Kobayashi, N. | +6

7

Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Kikuchi, T. | Takeuchi, Y. | Nouso, K. | +18

8

Treatment options for solitary hepatocellular carcinoma ≤5 cm : surgery vs. ablation: a multicenter retrospective study

enthalten in: Journal of liver cancer | 2024

von Kariyama, K. | Nouso, K. | Hiraoka, A. | +15

CommentIn: J Liver Cancer. 2024 Mar;24(1):1-2. - PMID 38481357

9

mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response

enthalten in: Journal of gastroenterology and hepatology | 2024

von Tada, T. | Kumada, T. | Hiraoka, A. | +9

10

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]